Viewing Study NCT01242267


Ignite Creation Date: 2025-12-25 @ 12:46 AM
Ignite Modification Date: 2026-05-27 @ 3:23 AM
Study NCT ID: NCT01242267
Status: COMPLETED
Last Update Posted: 2023-01-03
First Post: 2010-11-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
Sponsor: Hackensack Meridian Health
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple myeloma View
None transplant View
None Multiple myeloma patients undergoing transplant View